These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32631525)

  • 21. Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework: Rigidification of D
    Giri R; Alberts I; Harding WW
    Chem Biol Drug Des; 2020 Aug; 96(2):825-835. PubMed ID: 32279445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides.
    Dziewczapolski G; Menalled LB; García MC; Mora MA; Gershanik OS; Rubinstein M
    Neuroreport; 1998 Jan; 9(1):1-5. PubMed ID: 9592037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
    Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
    J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of 3-aryl-1-[(4-phenyl-1-piperazinyl)butyl]indazole derivatives and their affinity to 5-HT1A serotonin and dopamine D1 receptors.
    Andronati S; Sava V; Makan S; Kolodeev G
    Pharmazie; 1999 Feb; 54(2):99-101. PubMed ID: 10084155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of C10 nitrogen-containing aporphines with dopamine D
    Karki A; Juarez R; Namballa HK; Alberts I; Harding WW
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127053. PubMed ID: 32107165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of human D1 and D5 dopaminergic G protein-coupled receptors: lessons from mutagenesis of a conserved serine residue in the cytosolic end of transmembrane region 6.
    Plouffe B; Tiberi M
    Methods Mol Biol; 2013; 964():141-80. PubMed ID: 23296783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
    Macdonald GJ; Branch CL; Hadley MS; Johnson CN; Nash DJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Winborn KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Watson JM; Wood M; Parker SG; Ashby CR
    J Med Chem; 2003 Nov; 46(23):4952-64. PubMed ID: 14584946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrazides of clozapine: a new class of D1 dopamine receptor subtype selective antagonists.
    Sasikumar TK; Burnett DA; Zhang H; Smith-Torhan A; Fawzi A; Lachowicz JE
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4543-7. PubMed ID: 16809034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
    Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azepinoindole derivatives with high affinity for brain dopamine and serotonin receptors.
    Maryanoff BE; McComsey DF; Martin GE; Shank RP
    Bioorg Med Chem Lett; 1998 Apr; 8(8):983-8. PubMed ID: 9871525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
    Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
    J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural manipulation on the catecholic fragment of dopamine D(1) receptor agonist 1-phenyl-N-methyl-benzazepines.
    Zhang J; Huang J; Song Z; Guo L; Cai W; Wang Y; Zhen X; Zhang A
    Eur J Med Chem; 2014 Oct; 85():16-26. PubMed ID: 25076379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selection of a commercial route for the D1 antagonist Sch-39166.
    Hou D; Schumacher D
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):792-9. PubMed ID: 11899619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABAergic imbalance is normalized by dopamine D
    Gálvez-Rosas A; Avila-Luna A; Valdés-Flores M; Montes S; Bueno-Nava A
    Psychopharmacology (Berl); 2019 Jul; 236(7):2211-2222. PubMed ID: 30859334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D1B receptor chimeras reveal modulation of partial agonist activity by carboxyl-terminal tail sequences.
    Sugamori KS; Scheideler MA; Vernier P; Niznik HB
    J Neurochem; 1998 Dec; 71(6):2593-9. PubMed ID: 9832160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voltage-Dependent Dopamine Potency at D
    Ågren R; Sahlholm K
    Front Pharmacol; 2020; 11():581151. PubMed ID: 33117177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
    Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.